Bafna Pharmaceuticals Limited

NSE BAFNAPH.NS

Bafna Pharmaceuticals Limited Dividend Per Share for the year ending March 31, 2024: USD -0.00

Bafna Pharmaceuticals Limited Dividend Per Share is USD -0.00 for the year ending March 31, 2024, a 0.00% change year over year. Dividend per share represents the dividends distributed per share. Indicates dividend yield potential on a per-share basis.

Bafna Pharmaceuticals Limited Dividend Per Share for the year ending March 31, 2023 was USD -0.00, a 0.00% change year over year.
Bafna Pharmaceuticals Limited Dividend Per Share for the year ending March 31, 2022 was USD -0.00, a 0.00% change year over year.
Bafna Pharmaceuticals Limited Dividend Per Share for the year ending March 31, 2021 was USD -0.00, a 0.00% change year over year.
Bafna Pharmaceuticals Limited Dividend Per Share for the year ending March 31, 2020 was USD -0.00, a 0.00% change year over year.

Key data

Date	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)

NSE: BAFNAPH.NS

Bafna Pharmaceuticals Limited

CEO	Mr. Bansilal Mahaveer Chand Bafna
IPO Date	Nov. 12, 2012
Location	India
Headquarters	Bafna Towers
Employees	363
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Chemicals & Advanced Materials Clinical Trials Pharmaceuticals

Description

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company provides delayed and sustained release, chewable, and orally disintegrating tablets. It also exports its products. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India.

Key trends

Past 5 years